Literature DB >> 11543691

A vaccine against dental caries: an overview.

S M Michalek1, J Katz, N K Childers.   

Abstract

Dental caries continues to be a costly and prevalent oral disease. Research efforts towards developing a well tolerated and effective vaccine against dental caries were initiated following the demonstration of a specific bacterial aetiology for this disease. The cariogenic mutans streptococci are the principal bacteria causing this disease. Specific immune defence against these bacteria is provided mainly by secretory immunoglobulin (Ig) A antibodies present in saliva, which are generated by the common mucosal immune system. Progress in the development of a vaccine against dental caries has increased due to both advancements in molecular biology and our understanding of the mucosal immune system and mucosal vaccines. Advancements in molecular biology have facilitated the cloning and functional characterisation of virulence factors of the mutans streptococci, including the cell-surface fibrillar proteins, which mediate adherence to the tooth surface, and the glucosyltransferase enzymes, which synthesise adhesive glucans and allow microbial accumulation on the teeth. Current strategies for immunisation against dental caries are using these virulence factors as key antigens and incorporating them into novel mucosal vaccine systems and delivering them with or without adjuvants to mucosal IgA inductive sites. The most popular routes of mucosal immunisation are via the oral or nasal route. The mucosal immune system is functional in newborn infants, who develop salivary IgA antibodies as they become colonised by oral micro-organisms. Mucosal immunisation strategies result in the induction of salivary IgA antibody responses and pose fewer problems than parenteral injection of antigen. Therefore, mucosal immunisation of infants prior to the appearance of their first teeth may be a well tolerated and effective way to induce immunity against the colonisation of teeth by mutans streptococci and protection against subsequent dental caries. The purpose of this article is to provide an overview of the recent progress on the development of a vaccine against infection by Streptococcus mutans for the prevention of dental caries, with emphasis on the mucosal immune system and vaccine design.

Entities:  

Mesh:

Year:  2001        PMID: 11543691     DOI: 10.2165/00063030-200115080-00002

Source DB:  PubMed          Journal:  BioDrugs        ISSN: 1173-8804            Impact factor:   5.807


  13 in total

Review 1.  Microbial/host interactions: mechanisms involved in host responses to microbial antigens.

Authors:  Suzanne M Michalek; Jannet Katz; Noel K Childers; Michael Martin; Daniel F Balkovetz
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

3.  Alterations in immunodominance of Streptococcus mutans AgI/II: lessons learned from immunomodulatory antibodies.

Authors:  Rebekah A Robinette; Kyle P Heim; Monika W Oli; Paula J Crowley; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2013-11-16       Impact factor: 3.641

4.  Induction of neutralizing antibodies in mice immunized with an amino-terminal polypeptide of Streptococcus mutans P1 protein produced by a recombinant Bacillus subtilis strain.

Authors:  Milene B Tavares; Bruno M Silva; Rafael C M Cavalcante; Renata D Souza; Wilson B Luiz; Juliano D Paccez; Paula J Crowley; L Jeannine Brady; Luís C S Ferreira; Rita C C Ferreira
Journal:  FEMS Immunol Med Microbiol       Date:  2010-03-10

5.  Redirecting the humoral immune response against Streptococcus mutans antigen P1 with monoclonal antibodies.

Authors:  Monika W Oli; Nikki Rhodin; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 6.  Vaccines and photodynamic therapies for oral microbial-related diseases.

Authors:  Pei-Feng Liu; Wen-Hong Zhu; Chun-Ming Huang
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

7.  Levels of parotid and submandibular/sublingual salivary immunoglobulin A in response to experimental gingivitis in humans.

Authors:  R Seemann; S J Hägewald; V Sztankay; J Drews; M Bizhang; A Kage
Journal:  Clin Oral Investig       Date:  2004-08-14       Impact factor: 3.573

8.  Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

9.  Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen.

Authors:  Dragana Ajdić; William M McShan; Robert E McLaughlin; Gorana Savić; Jin Chang; Matthew B Carson; Charles Primeaux; Runying Tian; Steve Kenton; Honggui Jia; Shaoping Lin; Yudong Qian; Shuling Li; Hua Zhu; Fares Najar; Hongshing Lai; Jim White; Bruce A Roe; Joseph J Ferretti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-23       Impact factor: 11.205

10.  Effects of ginkgoneolic acid on the growth, acidogenicity, adherence, and biofilm of Streptococcus mutans in vitro.

Authors:  Jinzhi He; Shida Wang; Tingxi Wu; Yangpei Cao; Xin Xu; Xuedong Zhou
Journal:  Folia Microbiol (Praha)       Date:  2012-09-06       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.